Navigation Links
AbbeyMoor Medical Receives Category I CPT(R) Code for The Spanner(TM) Prostatic Stent Procedure
Date:10/14/2009

PARKERS PRAIRIE, Minn., Oct. 14 /PRNewswire/ -- AbbeyMoor Medical Inc. announced today they have been granted a Category I CPT code by the American Medical Association (AMA) for The Spanner(TM) temporary prostatic stent insertion procedure. This important action, effective in January 2010, upgrades The Spanner from a Category III emerging technology procedure code to a Category I procedure code for established procedures. This major milestone for AbbeyMoor Medical will provide access to The Spanner for urologists and their patients across the United States.

The Spanner is the only FDA approved temporary prostatic stent. Patients who wear the stent have indicated their preference for The Spanner over catheterization.

"It is our goal to provide an improved quality of life for men suffering acute urinary retention," said John Reid, Co-Founder and CEO of AbbeyMoor Medical. "Receiving this Category I CPT code is an essential step in bringing this ingenious product to the national market. The code will assist physicians and their office staff in obtaining timely and accurate reimbursement for stent insertions in the office setting."

It is estimated that over 20 million American men suffer from symptoms of benign prostatic hyperplasia (BPH) with approximately 8 million men diagnosed with the condition. There are many options available for the treatment of BPH with medical therapy, traditional surgery, and an ever increasing number of minimally invasive treatment options. Many men choose one of several available minimally invasive office based treatments for their BPH to avoid the risks associated with surgery.

"We have several patients each month who benefit from The Spanner," said Douglas Chinn, urologist from Arcadia, CA. "We are excited to have this ingenious device now widely available to our patients and to have the ability to restore their quality of life," he added. Chinn is co-author of a recent article about the stent in Urology Times (July 2009): "How to manage BOO (bladder outlet obstruction) with temporary prostatic stenting."

The relative value units (RVUs) used to establish the payment amounts for The Spanner procedure will be published by the Centers for Medicare and Medicaid Services in the Federal Register later this fall. CPT code 53855 will replace Category III CPT code 0084T, effective January 1, 2010.

About CPT Coding

In addition to facilitating reimbursement in government programs such as Medicare and Medicaid, CPT codes are used by other insurance companies and government payers to describe health care services and procedures. In the development of new and revised Category I CPT codes the AMA requires:

  • That the service/procedure receive approval/clearance from the FDA
  • That the service/procedure is performed across the country in multiple locations
  • That many physicians perform the service/procedure
  • That the clinical efficacy for the service/procedure has been well established and documented.

More information about CPT codes and the process of establishing CPT codes is available at the AMA's website: www.AMA-Assn.org

About The Spanner

The Spanner is a temporary prostatic stent designed to aid men who are experiencing difficulty in urination following a minimally invasive treatment for their BPH. Device placement can be safely performed in a physician's office and does not require cystoscopy or anesthesia. The Spanner is approved by the FDA for use up to 30 days in patients who have undergone minimally invasive treatment for benign prostatic hyperplasia following initial post treatment catheterization.

About AbbeyMoor Medical

AbbeyMoor Medical is a privately held company that develops and manufactures innovative medical devices focused on the management and treatment of male voiding dysfunction. The company's initial focus is on the development and commercialization of The Spanner.

For more information, please visit www.thespanner.com

SOURCE AbbeyMoor Medical Inc.


'/>"/>
SOURCE AbbeyMoor Medical Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Solta Medical Announces FDA 510(k) Clearance of New Fraxel re:store(R) Dual Laser System
2. Breast Cancer Survivors and Patients Encouraged to Have Medical History Readily Available
3. Timm Medical Technologies and Ferring Pharmaceuticals Enter Exclusive Co-Promotion Agreement for Prosed(R) DS
4. Cardiva Medical, Inc. Announces the Departure of its President and his Appointment as CEO of Innovative Energy, Inc.
5. Vibrant Exhibit Hall Features Innovative Medical Technology at AdvaMed 2009
6. Luminous Medical, Inc. Secures Exclusive Rights to Glucose Sensor for Its Automated Glucose Monitor
7. Growing Supply Chain Complexity Increasing Impact on Medical Device Company Operations
8. Award-Winning Medical Technology From Germany
9. Cantel Medicals Crosstex Subsidiary Launches New Specially Treated Face Mask Effective Against H1N1 Influenza
10. ATS Medical Announces Receipt of CE Mark for the New ATS CryoMaze 10-S Probe
11. Sonitus Medical Technology Ranks #1 on Cleveland Clinics Top 10 Medical Innovations for 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... April 27, 2016 Shire plc (LSE: ... Poulton , Chief Financial Officer, will present at the Deutsche ... MA on Wednesday, May 04, 2016, 10:00 am ... be available on the Presentations and Webcasts section of Shire,s ... the webcast will be available on this same website for ...
(Date:4/27/2016)... 27, 2016 Oasmia Pharmaceutical ... of a new generation of drugs within human ... results for Paclical/Apealea in the Phase III study ... epithelial ovarian cancer. These preliminary results showed non-inferiority ... with carboplatin versus Taxol in combination with carboplatin. ...
(Date:4/27/2016)... , April 27, 2016 ... reach USD 2.06 billion by 2022, according to ... Increasing consumer awareness towards a healthy lifestyle is ... seven years.      (Logo: http://photos.prnewswire.com/prnh/20150105/723757 ... coupled with rising health treatment expenditure has urged ...
Breaking Medicine Technology:
(Date:4/28/2016)... ... April 28, 2016 , ... ... the open availability of a new CDISC standard, Clinical Trial Registry (CTR) ... trials. This innovative standard will make it possible to build applications that ...
(Date:4/28/2016)... ... April 28, 2016 , ... Trinity Health, one ... a leading force in the fight to reduce tobacco use and its deadly ... can help reduce tobacco use. The initiative brings together two organizations committed to ...
(Date:4/28/2016)... ... April 28, 2016 , ... In 2011, TIME magazine named Herr the “Leader ... biomechatronics, technology that marries human physiology with electromechanics. He continues that work as Director ... Founder of BionX , a leader in the field of prosthetic devices. , ...
(Date:4/28/2016)... ... April 28, 2016 , ... Cognizin® Citicoline is one of ... in the Healthy Ageing category, Cognizin® is being considered for this prestigious honor ... can include everything from antioxidants, lipids, proteins, and botanicals. NutraIngredients will choose a ...
(Date:4/28/2016)... ... ... Card reminds us that May is National Stroke Awareness Month. According to the Centers ... in the United States; someone has one every 40 seconds. Annually, almost 800,000 strokes ... old. A stroke is when blood flow to the brain is blocked or when ...
Breaking Medicine News(10 mins):